Nima Farzan
Director/Miembro de la Junta en KEROS THERAPEUTICS, INC. .
Fortuna: - $ al 30/04/2024
Origen de la red de primer grado Nima Farzan.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 22 | |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA.
17
| Subsidiary | Internet Software/Services | 17 |
| Public Company | Pharmaceuticals: Major | 16 | |
The Hamlin School
2
| Private Company | 2 | |
DoubleTwist, Inc.
 DoubleTwist, Inc. Miscellaneous Commercial ServicesCommercial Services Doubletwist, Inc. provides genomic information and bioinformatics analysis technologies. The company is headquartered in Oakland, CA.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Nima Farzan a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Washington University in St. Louis | College/University | Undergraduate Degree Graduate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Public Communications Contact General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| HUMANIGEN, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Founder Chief Operating Officer Corporate Officer/Principal | |
| PRECIGEN, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member Director/Board Member | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
| University of Oxford | College/University | Graduate Degree Undergraduate Degree | |
| Yale University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Maryland | College/University | Corporate Officer/Principal Undergraduate Degree | |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | General Counsel Sales & Marketing General Counsel | |
| SCISPARC LTD. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
| COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Director/Board Member Director/Board Member | |
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| ALECTOR, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree | |
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| ARVINAS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Aliment Capital Llc
 Aliment Capital Llc Investment ManagersFinance Aliment Capital LLC (Aliment Capital) is a venture capital subsidiary of Pontifax Management Co. Ltd. founded in 2014 by Philip Robert Erlanger and Ben Belldegrun. The firm is headquartered in California, United States. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Pontifax (Israel) IV LP
 Pontifax (Israel) IV LP Financial ConglomeratesFinance Part of Pontifax Management Co. Ltd., Pontifax (Israel) IV LP is an investment services provider. The company is based in Hertsliya, Israel and was founded in 2015. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| ELOXX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| Pontifax Management 4 Gp 2015 Ltd. | Corporate Officer/Principal Corporate Officer/Principal | ||
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member | |
| THESEUS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Lutris Pharma Ltd.
 Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Lutris Pharma Ltd. is working on the improvement of the anti-cancer therapy effectiveness and the quality of life for patients that are treated with Epidermal Growth Factor Receptor Inhibitors. The company was founded on December 14, 2015 and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Founder | |
Xinthera, Inc.
 Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
| PARDES BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Founder | |
Foresite Life Sciences Corp.
 Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA. | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal | |
Paros Bio, Inc.
 Paros Bio, Inc. BiotechnologyHealth Technology Paros Bio, Inc. is a company that specializes in gene therapy for neurodegenerative diseases. The company is based in Boston, MA. Specifically, they are developing a gene replacement approach to treat autosomal dominant Alzheimer's disease caused by mutations in the presenilin 1 gene. The company's therapy directly addresses the underlying genetic cause of the disease. | Biotechnology | Director/Board Member Director/Board Member | |
| COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman |
Estadísticas
Internacional
| Estados Unidos | 42 |
| Israel | 8 |
| Reino Unido | 2 |
Sectorial
| Health Technology | 33 |
| Consumer Services | 12 |
| Finance | 6 |
Operativa
| Director/Board Member | 365 |
| Corporate Officer/Principal | 123 |
| Independent Dir/Board Member | 97 |
| Undergraduate Degree | 47 |
| Chief Tech/Sci/R&D Officer | 44 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| James Tananbaum | 60 |
| Carl Gordon | 59 |
| Tomer Kariv | 46 |
| Ran Nussbaum | 38 |
| Mary Gray | 27 |
| Charles Crocker | 27 |
| Howard Rosen | 26 |
| Dean Mitchell | 22 |
| David Chung | 21 |
| Jakob Loven | 19 |
| Alon Lazarus | 18 |
| Julius Knowles | 17 |
| Linda Rubinstein | 16 |
| Keith Flaherty | 16 |
| Arjun Goyal | 16 |
- Bolsa de valores
- Insiders
- Nima Farzan
- Conexiones Empresas
